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Abstract
Background: Corticobasal syndrome (CBS) is characterized by multifaceted motor system dysfunction and cognitive
disturbance; distinctive clinical features include limb apraxia and visuospatial dysfunction. Transcranial magnetic stimulation
(TMS) has been used to study motor system dysfunction in CBS, but the relationship of TMS parameters to clinical features
has not been studied. The present study explored several hypotheses; firstly, that limb apraxia may be partly due to
visuospatial impairment in CBS. Secondly, that motor system dysfunction can be demonstrated in CBS, using threshold-
tracking TMS, and is linked to limb apraxia. Finally, that atrophy of the primary motor cortex, studied using voxel-based
morphometry analysis (VBM), is associated with motor system dysfunction and limb apraxia in CBS.
Methods: Imitation of meaningful and meaningless hand gestures was graded to assess limb apraxia, while cognitive
performance was assessed using the Addenbrooke’s Cognitive Examination – Revised (ACE-R), with particular emphasis
placed on the visuospatial subtask. Patients underwent TMS, to assess cortical function, and VBM.
Results: In total, 17 patients with CBS (7 male, 10 female; mean age 64.4+/2 6.6 years) were studied and compared to 17
matched control subjects. Of the CBS patients, 23.5% had a relatively inexcitable motor cortex, with evidence of cortical
dysfunction in the remaining 76.5% patients. Reduced resting motor threshold, and visuospatial performance, correlated
with limb apraxia. Patients with a resting motor threshold ,50% performed significantly worse on the visuospatial sub-task
of the ACE-R than other CBS patients. Cortical function correlated with atrophy of the primary and pre-motor cortices, and
the thalamus, while apraxia correlated with atrophy of the pre-motor and parietal cortices.
Conclusions: Cortical dysfunction appears to underlie the core clinical features of CBS, and is associated with atrophy of the
primary motor and pre-motor cortices, as well as the thalamus, while apraxia correlates with pre-motor and parietal atrophy.
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Introduction
Corticobasal syndrome (CBS) is a neurodegenerative disorder
characterized by a combination of cognitive deficits and multi-
faceted motor system dysfunction,[1–4] with asymmetric rigidity,
bradykinesia, and prominent asymmetric limb apraxia.[5] In
addition, cognitive dysfunction is now recognized as a core clinical
feature of CBS. Patients typically develop progressive disturbances
of language or behavior, which overlap with those seen in
frontotemporal dementia (FTD). Unlike other patients within the
FTD spectrum, visuospatial dysfunction is characteristic,[4,6–8]
and has been included as a component of most clinical diagnostic
criteria for CBS.[9–11]
Transcranial magnetic stimulation of the motor cortex has been
used to explore motor system dysfunction in CBS. Previous studies
have demonstrated altered resting motor threshold (RMT) [12,13]
and reduced short-interval intracortical inhibition (SICI).[12–15]
These abnormalities have been attributed to motor cortex
dysfunction, although the role of concomitant basal ganglia
dysfunction remains unclear. The relationship of cortical dysfunc-
tion to clinical symptoms and pathology has not been studied.
Although apraxia may be seen in other neurodegenerative
diseases,[16,17] the severity of asymmetric limb apraxia appears to
be distinctive in CBS [2,3] and constitutes an important diagnostic
feature.[9–11] Apraxia may be defined as the inability to perform
a motor task, despite intact power, sensation, coordination,
comprehension and cooperation [18] and is typically the earliest
symptom in CBS.[3] The classification of limb apraxia is complex,
with distinctions made between transitive (involving tool use) and
intransitive (actions not requiring tools, such as ‘‘waving’’) actions,
or subdivision of apraxia into ideomotor, ideational, and limb-
kinetic types.[18] Some forms of apraxia are associated with left
hemisphere pathology, whereas others may be associated with
right hemisphere damage.[18–20] Furthermore, some apraxia
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subtypes have been attributed to parietal pathology,[21,22] but
other structures including the motor cortex (primary and
supplementary) and the basal ganglia, have also been implicat-
ed.[17,19,21] Atrophy of the primary motor cortex, basal ganglia,
or parietal lobe is common in CBS,[23,24] suggesting that
dysfunction of these regions may contribute to the development
of apraxia in the syndrome.
A range of pathologies may present as CBS. Initial reports
emphasized an underlying tauopathy (referred to pathologically as
corticobasal degeneration), with similar features to those seen in
many cases of frontotemporal lobar degeneration. More recently
Alzheimer’s disease, TAR DNA-binding protein 43 intraneuronal
inclusions, and progressive supranuclear palsy have been reported
in cases of CBS.[4,23–26] The pattern of cortical atrophy varies
markedly in CBS, depending on the underlying pathology,[24,27]
but whether the pattern of atrophy explains the frequency and
severity of apraxia or motor system dysfunction in CBS is
unknown.
Although the pattern of cerebral atrophy in CBS varies
significantly, previous studies have consistently demonstrated
atrophy of the primary motor cortex.[24,27] This finding is
consistent with reports of motor cortex dysfunction studied using
transcranial magnetic stimulation,[12–15] although the relation-
ship between physiological changes and cerebral atrophy has not
been investigated. Whether primary motor cortex involvement
contributes to apraxia is not known.
The present study explored several hypotheses; firstly, that limb
apraxia in CBS – in part – reflects impaired visuospatial
processing. Secondly, that motor system dysfunction can be
demonstrated in CBS, using paired-pulse threshold tracking
transcranial magnetic stimulation, and that motor system
dysfunction and limb apraxia both reflect pathological involve-
ment of cortical and subcortical motor structures. Finally, that
atrophy of the primary motor cortex, studied using voxel-based
morphometry analysis (VBM), is associated with motor system
dysfunction and limb apraxia in CBS.
Materials and Methods
Study Participants
Patients with a clinical diagnosis of CBS were recruited
consecutively from a specialist cognitive disorders clinic. The
study was approved by the South Eastern Sydney Local Health
District Human Research Ethics Committee and performed after
written informed consent was obtained from all participants. In
accordance with PLoS One policies, the data from the present
study may be made available on request. The diagnosis of CBS
was established through a detailed clinical assessment and
neuropsychological evaluation, and all patients met recent
diagnostic criteria.[11] Structural imaging with magnetic reso-
nance imaging was also performed, but the results were not used to
select or exclude patients for the present study. Patients with other
alternative diagnoses notably idiopathic Parkinson’s disease,
progressive supranuclear palsy, vascular dementia, or psychiatric
disease were also excluded.
In total, 34 participants were included in the study; 17 with CBS
and 17 control subjects. Of the 17 patients with CBS, 41.2% were
male and the mean age at assessment was 64.4+/26.6 years. The
mean symptom duration was 54.6+/218.0 months. A database of
volunteers was used to recruit control subjects. Each individual
patient was matched to a control subject of the same gender (male
gender in 41.2%). Where possible CBS patients were matched to a
control subject of the same age in years. In practice, control
subject age was matched to within 2 years of CBS patient age in all
but two cases, in which the age difference was 3 and 4 years
respectively. The mean age of control subjects was 64.4+/27.3
years and this was not significantly different from that of CBS
patients (P = 1.0). Controls and CBS patients were not specifically
matched for handedness. Control subjects were included if they
had no history of neurological diseases such as dementia, stroke,
multiple sclerosis, Parkinson’s disease or other movement disor-
ders. Controls who demonstrated cognitive impairment on
neuropsychological evaluation or incidental abnormalities on
MRI scanning were excluded from the study.
Clinical Assessment
Apraxia was systematically assessed using a semi-structured
approach. Specifically, patients were asked to imitate 4–5
meaningful (for example; the ‘‘Thumb’s up’’ or ‘‘A-Okay’’
gestures) and 4–5 meaningless hand gestures, using both the right
and left hands,[28] to allow a judgment of the severity of limb
apraxia. The assessments were videotaped and the overall level of
apraxia in the right and left upper limbs was graded on a 4 point
scale (no apraxia = 0, mild = 1, moderate = 2, severe = 3)
independently by two examiners (JRH and JRB). Mild (score = 1)
apraxia was defined as occasional/minor errors or hesitancy with
the correct target gesture achieved. Moderate (score = 2) apraxia
was defined as consistent errors of hand position, but with some
target gestures achieved. Severe (score = 3) apraxia was defined as
the inability to achieve any target accurately. Using this grading
system, the overall rater scores did not differ significantly between
individual raters (P = 0.154, see Table S1). Furthermore, there was
a strong and highly significant correlation between scores from
both raters (P = 0.005, Spearman’s coefficient 0.75). Finally, inter-
rater reliability analyses, performed using the intraclass correlation
coefficient, revealed excellent convergence between the two raters;
overall score ( = 0.848). Similarly, patients were asked to imitate
2–3 oro-buccal gestures (for example; ‘‘lick your lips’’ or ‘‘cough’’)
to judge the severity of oro-buccal apraxia. Individual examiner
ratings from the right (0–3) and left (0–3) upper limbs were
averaged to produce scores for limb-meaningful (0–6 points), limb-
meaningless (0–6 points), and the oro-buccal score was added to
produce an overall apraxia score (0–15 points), with higher scores
indicating a greater degree of apraxia. Other components of
apraxia – such as imaginary tool usage (for example; ‘‘brush your
teeth’’ or ‘‘comb your hair’’) were also included in the assessment,
but were not graded consistently (i.e. formal grading was not
completed on all patients). These components of the assessment
were therefore excluded from the analysis and were not used to
calculate the apraxia scores. Imitation, rather than pantomime (i.e.
production of meaningful gestures from memory) was chosen, as
imitation may be more sensitive to disturbances of praxis in
CBS.[29,30]
All patients underwent a standardized clinical assessment by a
single examiner (JRB) to detect clinical evidence of motor system
dysfunction such as weakness and hyperreflexia.[31] Muscle power
was graded according to the Medical Research Council grades,
after taking into account the degree of limb apraxia, and
individual muscle scores were added to calculate the Medical
Research Council sum-score (MRCSS) for each patient. Hyper-
reflexia, defined as exaggerated deep tendon reflexes elicited with
minimal stimulus, or pathological spread of reflexes, was recorded
in each patient.
Since a disease specific functional rating scale has not been
developed for CBS, the Amyotrophic Lateral Sclerosis Functional
Rating Scale – Revised (ALSFRS-R),[32] was chosen as a
validated measure of motor functional capacity.[33] The
ALSFRS-R comprises 12 questions regarding ability to perform
Apraxia and Motor Dysfunction in CBS
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everyday tasks; each response is graded from 0–4 with functional
impairment reflected by reduced scores. In addition to ALSFRS-R
totals, bulbar, fine motor, gross motor and respiratory ALSFRS-R
sub-scores were also calculated for each patient.
Cognitive testing
Cognitive screening was performed using the Addenbrooke’s
Cognitive Examination – Revised (ACE-R).[34,35] The ACE-R is
a brief cognitive screening tool that includes an assessment of five
cognitive domains, and has been used to evaluate cognitive
dysfunction in CBS previously.[8] The domains examined by the
ACE-R include: attention (18 points), memory (26 points), verbal
fluency (14 points), language (26 points) and visuospatial ability (16
points). The ACE-R is scored out of 100 points and a score at or
below 88/100 detects dementia with a sensitivity of 94% and
specificity of 89%.[35] The visuospatial component of the ACE-R
consists of tasks that require the use of a pencil (e.g. copy of
interlocking pentagons, drawing of a clock-face), as well as tasks
that simply require interpretation of visual information (e.g. dot
counting, partial letter recognition). Marked limb apraxia might be
expected to impair performance on tasks requiring manipulation
of a pencil, particularly if the dominant hand is maximally
impaired. With this in mind, performance on both subcomponents
of the ACE-R visuospatial task, designated as ‘‘written’’ and
‘‘visual’’ visuospatial subcomponents (each scored out of 8 points),
were analyzed independently.
Neurophysiological Assessments
The paired pulse, threshold-tracking transcranial magnetic
stimulation protocol was used to assess cortical function in CBS
patients and control subjects.[36–38] This testing protocol was
preferred over the constant stimulus paired pulse technique as the
motor evoked potential amplitude often varies significantly from
stimulus to stimulus thereby necessitating multiple stimuli, with
subsequent averaging, at each level of stimulus intensity.[39] The
threshold-tracking paradigm overcomes this potential limitation by
tracking a target response of 0.2 mV, which lies in the middle of
the linear logarithmic stimulus-response relationship over a
hundred-fold range of responses from about 0.02 to 2 mV.[40]
As such, larger variations in the MEP amplitude would translate to
smaller variations in the stimulus intensity (the outcome variable),
potentially enabling more accurate recordings of TMS parame-
ters. Specifically, using the paired-pulse threshold tracking
protocol stimuli are repeated until the target response has been
achieved and averaging of multiple responses is not required. This
technique has been successfully used in frontotemporal demen-
tia,[31] as well as motor neuron disease and related disor-
ders.[33,36–38,41]
According to the threshold tracking protocol, the motor cortex
was stimulated using magnetic pulses delivered via a 90 mm
magnetic circular coil placed over the subject’s scalp, and the
resultant motor evoked potentials were recorded from the
abductor pollicis brevis muscle in the hand at rest. Patients were
repeated asked to relax the hand being tested and the protocol was
recommenced if voluntary or involuntary (e.g. mild dystonia)
motor activity interfered with electromyographic silence. By
default, the right hand was used for transcranial magnetic
stimulation studies; if a stable response could not be obtained on
the right, the left hand was studied. If a stable motor response
could not be obtained on either side, despite maximal stimulus
intensity, the motor cortex was classified as relatively inexcitable
and the protocol was ceased. In such cases, no subsequent
measures of cortical excitability could be determined. The optimal
coil position, defined, as the position that elicited the most stable
motor response, was determined first (See Figure 1A), followed by
the resting motor threshold (RMT). The RMT was defined as the
amount of stimulus required to evoke the target motor evoked
potential of 0.2 millivolts (mV). Provided a stable motor response
was obtained with single magnetic stimuli, the paired pulse
component of the protocol was initiated. In order to deliver pairs
of pulses, two high-power magnetic stimulators were connected via
a BiStim device (Magstim Co., Whitland, South West Wales, UK)
and used to deliver paired stimuli that could be set independently
and delivered through one coil. The first stimulus – the
conditioning impulse – was delivered at an fixed intensity of
70% RMT, and the second stimulus – the test impulse – was
varied in intensity to achieve the target motor evoked potential of
0.2 mV (See Figure 1B).
As the protocol proceeded, the time between conditioning and
test impulses – referred to as the interstimulus interval – was varied
from 1 to 20 milliseconds (ms). The motor responses were
amplified and filtered (3 Hz–3 kHz) using a GRASS ICP511 AC
amplifier (Grass-Telefactor, Astro-Med Inc., West Warwick, RI,
USA) and sampled at 10 kHz using a 12-bit data acquisition card
(National Instruments PCI-MIO-16E-4). The protocol was driven
by QTRACS software (Institute of Neurology, Queen Square,
London, UK).
In normal individuals, increased test impulse intensity is
required to produce the target motor response following a
conditioning impulse when the interstimulus interval is between
1–7 ms. This phenomenon, referred to as short interval intracor-
tical inhibition (SICI), reflects relative cortical inhibition induced
by the conditioning impulse at short interstimulus intervals. In the
present study SICI was defined as the increase in test impulse
intensity (i.e. test - RMT) required to achieve the target response at
interstimulus intervals of 1–7 ms, represented as a percentage of
RMT.[36,40] Peak SICI was recorded at an interstimulus interval
of 3.5 ms and average SICI was calculated as the mean of SICI
values recorded at each interstimulus interval from 1–7 ms. In
addition, the maximal motor evoked potential amplitude and
minimum motor evoked potential latency were recorded, and the
maximal cortical silent period was calculated. The maximal
cortical silent period was defined as the duration of electrical
silence recorded from the abductor pollicis brevis induced by
sustained, sub-maximal muscle contraction, following single pulse
magnetic stimulation.[42] The central motor conduction time was
calculated using the F-wave method.[43,44] The compound motor
action potential amplitude following electrical stimulation of the
median nerve at the wrist was recorded in millivolts (mV) from the
abductor pollicis brevis muscle in the hand using 5-mm Ag-AgCl
surface electrodes (ConMed, Utica, USA). The motor evoked
potential amplitude was also expressed as a percentage of
compound motor action potential amplitude.
Voxel-Based Morphometry
All 17 CBS patients and 17 age-matched healthy controls
underwent magnetic resonance imaging (MRI) according to a
standardized protocol using a 3-Tesla Phillips MRI scanner with
standard quadrature head coil (8 channels). The 3D T1-weighted
images were acquired with the following parameters: coronal
orientation, matrix 2566256, 200 slices, 161 mm2 in-plane
resolution, slice thickness 1 mm, TE/TR =2.6/5.8 ms, and
TFE/FFE Pulse sequence.
3D T1-weighted sequences were used to perform a VBM
analysis [45,46] using the Functional Magnetic Resonance
Imaging of the Brain (FMRIB) Software Library (FSL) software
package [47] (see http://www.fmrib.ox.ac.uk/fsl/fslvbm/index.
html). Tissue segmentation was carried out using FMRIB’s
Apraxia and Motor Dysfunction in CBS
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Automatic Segmentation Tool (FAST) [48] from brain-extracted
images. The resulting grey matter partial volume maps were
aligned to the Montreal Neurological Institute standard space
(MNI152) using the nonlinear registration approach via FMRIB’s
Nonlinear Image Registration Tool (FNIRT),[49,50] which uses a
b-spline representation of the registration warp field.[51] The
registered partial volume maps were then modulated (to correct
for local expansion or contraction) by dividing them by the
Jacobian of the warp field. The modulated images were smoothed
with an isotropic Gaussian kernel with a standard deviation of
3 mm (Full Width at Half Maximum: 8 mm). Finally, a voxel-wise
general linear model (GLM) was applied and permutation-based
non-parametric testing was used to form clusters with the
Threshold-Free Cluster Enhancement (TFCE) method.[52] Mul-
tiple comparison corrections were not performed as these often
exclude meaningful results in covariance analyses, which correlate
variables (i.e. RMT, SICI) with atrophy rather than compare
groups. Instead, uncorrected P values were used. To reduce the
likelihood of false positive correlations a more a stringent
significance level of P,0.001 and a contiguous cluster threshold
of 20 voxels were applied.[53–55]
Statistical Analysis
Statistical analysis was performed by a single author (JRB) and
carried out using the Statistical Package for Social Sciences
(version 19.0, SPSS Inc.; Chicago, IL, USA). The Wilcoxon signed
rank test was used to compare related measures (e.g. limb-
meaningful and limb-meaningless apraxia scores) in individual
patients, as well as compare apraxia scores between different
independent raters. Comparisons of neurophysiological data were
first made between patients with CBS and control subjects.
Subjects were later grouped according to their RMT; patients with
an RMT ,50% (RMT ,50%), patients with an RMT .50%
(RMT .50%), and patients with an inexcitable motor cortex
(inexcitable), and the three groups were compared. Neurophysi-
ological parameters could not be determined in patients with an
inexcitable motor cortex, so these patients were excluded from
several subsequent analyses. In excitable patients, an RMT of 50%
was used to define the groups as this approximated the median
recorded RMT for the patients in the study. Continuous variables
were analyzed using analysis of variance (ANOVA) when normally
distributed or the Kruskal–Wallis test when non-normally
distributed. Pair-wise comparisons were performed using the
student’s t test when the data was normally distributed and the
Mann-Whitney test when non-normally distributed. Categorical
data were analyzed using the Chi-Square test. Correlations
between continuous variables were performed using Spearman
correlation for non-normally distributed samples, after application
of the Bonferroni correction,[56] with a P-value of ,0.05
regarded as significant. Partial correlation was used to control
for potential confounding variables such as age and symptom
duration.
Results
As mentioned, 34 participants were included in the study; 17
with CBS and 17 age and gender matched controls. Of patients
with CBS, 7 (41.2%) were male. The mean age at assessment was
Figure 1. The paired-pulse transcranial magnetic stimulation protocol. (A) Motor evoked potentials (¥) were recorded from the abductor
pollicis brevis muscle following magnetic stimulation of the motor cortex. The stimulus intensity required to achieve a target response of 0.2 mV,
defined as the resting motor threshold (RMT), was determined following a single magnetic stimulus. (B) Pairs of pulses were then delivered; a
conditioning impulse with an intensity set at 70% of RMT (*) followed by a test impulse which varied in intensity in order to maintain the target
response of 0.2 mV. As the protocol proceeded, the interval between the two stimuli – defined as the interstimulus interval (h) – was varied from 1–
20 ms. SICI was defined as the increase in test impulse intensity (i.e. test - RMT) required to achieve the target response at interstimulus intervals of 1–
7 ms, represented as a percentage of RMT. Please note, this figure (A) is simply intended to illustrate how the RMT is determined and the response
reproduced here does not necessarily represent an accurate measurement of RMT. Furthermore, the intensities of the stimuli used in A and B differ;
therefore the larger amplitude motor response in B does not necessarily reflect intracortical facilitation following the conditioning impulse.
doi:10.1371/journal.pone.0092944.g001
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64.4+/26.6 years and the mean symptom duration was 54.6+/
218.0 months. All but one CBS patient was right-hand dominant.
The maximally apraxic hand was the right hand in 10 CBS
patients, the left hand in 4 patients, and both hands were equally
affected in 3 patients. The single left-hand dominant patient had
bilateral limb apraxia. The right hand was studied in 11 (84.6%)
CBS patients with an excitable motor cortex, whereas the left hand
was used in 2 (15.4%) other patients. Motor dysfunction in CBS
patients was characterized by rigidity and bradykinesia, rather
than tremor (see Table S2). Postural instability was present in 9
(52.9%) CBS patients, but myoclonus and alien limb phenomenon
were uncommon, each present in only 3 (17.6%) patients. Further
details regarding the clinical presentation of CBS patients are
presented in Table 1.
Patients with CBS had moderate motor functional disability,
due predominantly to limb apraxia, parkinsonism, and rigidity,
rather than weakness (see Table 2). All patients had difficulty
producing meaningful and meaningless hand gestures, reflected by
increased limb-meaningful and limb-meaningless apraxia scores,
while 6 of 16 (37.5%) of CBS patients had evidence of oro-buccal
apraxia, albeit relatively mild as reflected in the oro-buccal apraxia
subscore (0.7+/- 0.9). There was no significant difference between
the mean limb-meaningful (3.6+/21.8) and limb-meaningless
(3.9+/21.9, P = 0.203) scores in CBS patients, while dystonia was
identified in 5 (29.4%) patients. CBS patients were functionally
impaired, reflected in markedly reduced fine and gross motor
ALSFRS-R sub-scores, despite normal limb power in all but one
patient.
Patients with CBS performed poorly on the visuospatial
component of the ACE-R (Table 2 and Table S3). As might have
been expected, CBS patients performed better on the ‘‘visual’’
subcomponent (6.2+/22.0) than on the ‘‘written’’ subcomponent
of the ACE-R (3.2+/23.0, P = 0.001, see Methods). However,
regardless of whether the right limb (dominant in all but 1 patient)
or left limb was maximally apraxic, there was no significant
difference in performance on the ‘‘visual’’ or ‘‘written’’ subcom-
ponents of the ACE-R, suggesting that poor performance on
visuospatial tasks was due to more than just difficulty manipulating
a pen or pencil. When correlations between the limb apraxia score
and measures of visuospatial performance (ACE-R visuospatial
subscore, ‘‘written’’ component) were performed, a strong and
highly significant correlation between the overall limb apraxia
score and the visuospatial ACE-R subscore (Corr. Co. =20.77,
P= 0.000) was detected. Even when the ‘‘written’’ components
were excluded, a strong and highly significant correlation was
detected between the overall limb apraxia score and the ‘‘visual’’
component of the ACE-R visuospatial subtask (Corr. Co.
=20.64, P= 0.006) was detected. Both correlations survived
Bonferroni threshold correction. Separately, there were no
significant correlations between either the overall limb apraxia
score, or the visuospatial subscore of the ACE-R, and age at
symptom onset or symptom duration. In addition, a correlation
between the overall limb apraxia and the memory subscore of the
ACE-R was detected (Corr. Co. =20.619, P= 0.008), and
survived Bonferroni correction. No other correlations between
the overall limb apraxia score and ACE-R subscores (e.g.
language) survived the Bonferroni correction.
Cortical function
Cortical function as assessed by transcranial magnetic stimula-
tion was markedly abnormal in CBS patients with two main
patterns of dysfunction. Firstly, 4 (23.5%) had a relatively
inexcitable motor cortex (Table 3), which meant that neurophys-
iological parameters (i.e. RMT, SICI, etc.) could not be measured
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in these patients. In contrast, only one control subject had a
relatively inexcitable motor cortex. Meanwhile, prominent cortical
abnormalities were detected among the remaining 76.5% of
patients who had an excitable motor cortex. Specifically, 5 (38.5%)
CBS patients with an excitable cortex had a reduced RMT
(,50%), compared to 1 (5.9%) control (P,0.05). In addition, peak
(CBS 0.8+/212.0, controls 16.6+/28.7; P,0.001) and average
SICI (CBS 0.5+/29.2, controls 11.0+/24.9; P,0.001) were
significantly reduced in the CBS group compared to controls
(Figure 2A and B). The maximum motor evoked potential
amplitude (CBS 4.2+/22.0, controls 1.8+/21.2; P,0.001) and
the motor evoked potential amplitude when expressed as a
percentage of compound motor action potential amplitude (CBS
59.1+/232.6%, controls 23.5+/214.3; P,0.001) were both
increased in CBS compared to controls (Figure 2C). Importantly,
there were no significant differences between RMT, peak SICI, or
average SICI when the hand used for transcranial magnetic
stimulation studies was the most apraxic or the least apraxic hand.
The relationship of cortical dysfunction to clinical
features
The CBS cohort was grouped according to the RMT (RMT
,50%, RMT .50%, and relatively inexcitable, see Methods) and
inter-group comparisons were performed (Table 4 and Table S4),
albeit with small numbers of patients in each group (a limitation of
the present study). Initially, there appeared to be no differences
between groups in age, symptom duration, motor weakness or
functional impairment (as assessed by the ALSFRS-R). Correla-
tions between the overall limb apraxia score and neurophysiolog-
ical markers of motor system dysfunction (RMT, Average SICI,
motor evoked potential amplitude expressed as a percentage of
compound motor action potential amplitude) were attempted with
relatively inexcitable patients excluded. A trend was detected for a
correlation between reduced RMT and the overall apraxia score
(Corr. Co. =20.64, P= 0.018), but this did not reach significance
after Bonferroni correction for multiple comparisons. This trend
(P= 0.07) remained even when partial correlation was used to
control for age and symptom duration.
Although there was no significant inter-group difference, the
CBS sub-group with reduced RMT had a markedly reduced
ACE-R total, suggesting severe cognitive impairment. Intergroup
comparisons revealed a significant (P,0.05) difference in the
visuospatial sub-score, with post-hoc pairwise comparisons con-
firming a significant reduction in the RMT ,50% group
compared to the RMT .50% group (P,0.05), and a trend for
reduced visuospatial sub-score compared to the relatively inexcit-
able group (P= 0.06). There were also trends for an intergroup
difference in performance on the memory and attention ACE-R
subscores, and post-hoc analyses revealed that the RMT ,50%
group had significantly lower memory and attention sub-scores
(P,0.05) compared to the RMT .50% group.
Neuroanatomical correlates of functional and clinical
characteristics
To further clarify the basis of cortical dysfunction, VBM
analyses were performed using transcranial magnetic stimulation
excitability measures (RMT, SICI) and the overall apraxia score.
Since RMT and SICI could not be measured in patients with a
relatively inexcitable motor cortex, these cases were excluded from
VBM analyses using SICI and RMT as covariates. Importantly,
visual inspection of MRI scans did not reveal differences in the
degree or pattern of atrophy in cortical and subcortical motor
structures between patients with a relatively inexcitable motor
cortex, and those in whom SICI and RMT could be measured. All
CBS patients were included in the overall apraxia score VBM
analysis. As demonstrated in Figure 3, reduced RMT and SICI
correlated with atrophy of the primary motor cortex, as well as the
basal ganglia and thalamus bilaterally. In addition, reduced RMT
correlated with atrophy of the pre-central gyrus, insula and left
anterior temporal lobe. Similarly, reduced SICI correlated with
insula, left medial frontal cortex and bilateral precuneus atrophy.
Finally, the degree of apraxia, indicated by an increased overall
apraxia score, correlated with atrophy of the medial frontal cortex
bilaterally, as well as the precuneus and posterior cingulate brain
regions (Figure 4).
Discussion
The present study has demonstrated significant cortical
dysfunction in a cohort of CBS patients. VBM established a
correlation between measures of cortical dysfunction and atrophy
of the primary motor cortex, as well as subcortical motor
structures. A relationship between the distinctive features of
Table 2. Clinical Characteristics of CBS patients.
CBS
Number of Patients 17
Male 7 (41.2%)
Age 64.4+/26.6
Symptom Duration (months) 54.6+/218.0
Hyperreflexia (% patients) 12 (70.6%)
Weakness (% patients) 1 (6.3%)
MRCSS Total (0–60) 59.8+/21.0
Apraxia
- Oro-buccal Apraxia (0–3) 0.7+/20.9
- Limb-Meaningful (0–6) 3.6+/21.8
- Limb-Meaningless (0–6) 3.9+/21.9
- Overall Apraxia Score (0–15) 7.8+/23.9
ALSFRS-R
- Bulbar 10.7+/21.4
- Fine Motor 5.7+/23.4
- Gross Motor 8.5+/22.9
- Respiratory 11.8+/20.5
- Total 36.7+/26.2
ACE-R
- Attention (18 points) 13.1+/25.7
- Memory (26 points) 15.5+/28.7
- Fluency (14 points) 5.4+/24.3
- Language (26 points) 17.2+/27.7
- Visuospatial (16 points) 9.2+/25.1
- Total (100 points) 60.1+/228.7
MMSE 19.7+/29.3
CBS patients had marked functional impairment with reduced ALSFRS-R fine
motor and gross motor sub-scores, despite normal limb power. CBS patients
were at least moderately cognitively impaired, with deficits in multiple
cognitive domains including visuospatial function. MRCSS = medical research
council sum score, ALSFRS-R = amyotrophic lateral sclerosis functional rating
score – revised, ACE-R = Addenbrooke’s cognitive examination – Revised,
MMSE = mini-mental status examination.
doi:10.1371/journal.pone.0092944.t002
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CBS, namely limb apraxia and visuospatial dysfunction, was
demonstrated and limb apraxia was linked to motor system
dysfunction, as measured by transcranial magnetic stimulation.
Altogether, the findings from the present study reinforce the role of
frontal lobe (i.e. primary motor cortex) dysfunction in the
development of the characteristic features of CBS.
Cortical dysfunction was indicated in the present series by a
high proportion of CBS patients exhibiting an RMT ,50%,
reduced SICI, and an increased motor evoked potential ampli-
tude. Although reduced SICI has been suggested in CBS
previously [12–15,57], reported changes in RMT have been
inconsistent. Some studies have demonstrated increased
RMT,[12,13,57,58] while others reported no change.[15] A
possible explanation for these discordant findings is that previous
studies compared mean RMT values, unlike the present approach
which grouped patients according to their RMT; one benefit of
this approach is that the distribution of RMT levels across the
entire CBS cohort can be taken into account. One limitation of the
present study was that side-to-side comparisons of cortical function
were not performed. As such, the relationship of any asymmetry in
responses to clinical features or underlying pathology is currently
unknown.
The mechanisms underlying cortical dysfunction in CBS remain
to be fully elucidated. RMT reflects the excitability of cortical
motor neurons,[59,60] but SICI reflects the function of inhibitory
intra-cortical circuits acting via GABAa receptors.[36,60,61]
Degeneration of inhibitory cortical inter-neurons may therefore
account for the transcranial magnetic stimulation results, partic-
ularly since reduced RMT and SICI correlated with atrophy of the
primary motor cortex. In addition, disinhibition of the motor
cortex by dysfunctional basal ganglia and thalamus may have
contributed.[12]
Why some patients with CBS have a relatively inexcitable motor
cortex while others have evidence of reduced RMT and SICI is
not clear, but may relate to different underlying pathologies. Given
that there were no differences between patients when grouped by
RMT in symptom duration, the degree or pattern of cortical
atrophy, motor weakness or functional impairment, advanced
disease stage alone is unlikely to explain the finding of a relatively
Figure 2. Cortical hyper-excitability in corticobasal syndrome. Patients with CBS had evidence of cortical hyper-excitability, with reduced SICI
(A), significantly (P,0.05) reduced average SICI (B), and significantly (P,0.05) increased motor evoked potential – expressed as a ratio of compound
motor action potential amplitude (C). Abbreviations: CBS = corticobasal syndrome, SICI = short-interval intracortical inhibition, MEP = motor
evoked potential, CMAP = compound motor action potential.
doi:10.1371/journal.pone.0092944.g002
Table 3. Cortical excitability in CBS patients.
CBS Control P value
RMT (mean, %) 54.9+/216.8 60.4+/28.4 NS
- In-excitable 4 (23.5%) 1 (5.9%)
- ,50% 5 (29.4%) 1 (5.9%) ,0.05*
- .50% 8 (47.1%) 15 (88.2%)
MEP amplitude (mV) 4.2+/22.0 1.8+/21.2 ,0.001
MEP amplitude (%) 59.1+/232.6 23.5+/214.3 ,0.001
Average SICI (%) 0.5+/29.2 11.0+/24.9 ,0.001
Peak SICI (%) 0.8+/212.0 16.6+/28.7 ,0.001
CMCT (ms) 7.1+/20.7 5.8+/21.8 ,0.05
Maximum CSP (ms) 198.6+/248.0 213.0+/226.5 NS
Some CBS patients had a relatively inexcitable motor cortex and transcranial
magnetic stimulation measures could not be determined. The remaining CBS
patients had evidence of cortical excitability, characterized by reduced peak
and average SICI, and increased motor evoked potential amplitude expressed
as a percentage of compound motor action potential amplitude. CBS =
corticobasal syndrome, RMT = resting motor threshold, SICI = short-interval
intra-cortical inhibition, MEP = motor evoked potential, CSP = cortical silent
period. *P-value calculated using the Chi-Square test for 263 table (i.e. CBD/
Control v Inexcitable/,50%/.50%)
doi:10.1371/journal.pone.0092944.t003
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inexcitable motor cortex in CBS. Moreover, the relatively
inexcitable group was not the most cognitively impaired. In
contrast, the RMT ,50% group demonstrated the greatest
cognitive impairment, with poorer performance on visuospatial,
attention, memory, and overall ACE-R scores. Poor performance
on the attention and memory ACE-R subtasks in CBS has been
linked to underlying Alzheimer’s disease [4] and visuospatial
dysfunction may be even more severely affected in CBS cases due
to Alzheimer’s disease than in other subtypes.[23,54] Finally,
RMT has been demonstrated to be significantly reduced in
Alzheimer’s disease.[62] As such, findings from the present series
may suggest that transcranial magnetic stimulation measures of
cortical dysfunction in CBS are related to underlying pathology.
However, the number of patients with an inexcitable cortex or
reduced RMT in the present study is relatively small, therefore
larger studies comparing cortical function across pathologically
defined CBS sub-groups will be required to confirm this possibility.
Apraxia assessment tools, for example the De Renzi ideomotor
apraxia test,[63] have been designed and published previously,
although no single instrument has been widely adopted. Many of
the previously reported assessment tools have attempted to
document the various sub-types of apraxia and may be lengthy
and time-consuming as a result. This may render them impractical
for routine clinical use.[64] Given that the focus of the present
study was to examine the relationships between limb apraxia and
motor system dysfunction, rather than on the sub-types of apraxia
per se, a simple but robust grading system based on imitation of
meaningless and meaningful hand gestures was used, rather than
using a more detailed instrument; this could be viewed as a
limitation of the present study. Nonetheless, our grading of apraxia
severity was simple and easy to apply, and related closely to the
level of functional impairment as assessed by the ALSFRS-R. As
such, our assessment was brief enough to use in the clinic, but still
appeared to yield useful, clinically relevant, information.
Several sub-types of apraxia have been described in CBS,
including oro-buccal, limb-kinetic, ideomotor (i.e. temporal or
spatial errors in goal-directed movements),[65] ideational (i.e.
impaired sequencing of tasks) [5] and conceptual (failure to use
tools correctly).[17,29,30] More significant impairment of transi-
tive gestures, rather than intransitive gestures, has also been
reported in previous studies.[17,30] The clinical and diagnostic
validity of such complex sub-classifications has not been
established in the context of CBS. Another challenge is to
differentiate any functional impairment due to dystonia and
rigidity, from that due to apraxia. As such, apparent asymmetry in
apraxia scores in the present study may have reflected superim-
posed dystonia or rigidity rather than just limb apraxia.
In the present study the degree of apraxia, reflecting impaired
imitation, was strongly correlated with performance on visuospa-
tial tasks, regardless of whether the task required manipulation of a
Table 4. Clinical features of CBS patients when grouped according to resting motor threshold.
RMT ,50% RMT .50% Inexcitable P -Value
Number of patients 5 8 4
Symptom Duration (months +/2 SD) 54.8+/213.1 59.3+/222.6 45.0+/211.5 NS
Age (years +/2SD) 62.4+/26.3 64.3+/25.9 67.3+/28.7 NS
MRCSS Total 60.0+/20.0 59.5+/21.4 60.0+/20.0 NS
Hyperreflexia (% patients) 4 (80%) 6 (75%) 2 (50%) NS
Apraxia
- Orobuccal Apraxia (0–3) 0.7+/20.8 0.2+/20.4 1.5+/21.3 NS
- Limb-Meaningful (0–6) 3.9+/22.2 2.8+/21.5 4.4+/21.6 NS
- Limb-Meaningless (0–6) 4.5+/21.9 3.3+/21.8 3.9+/22.3 NS
- Overall Apraxia Score (0–15) 9.1+/24.2 5.9+/22.6 9.4+/24.6 NS
ALSFRS-R
- Bulbar 11.4+/20.9 10.4+/21.6 10.3+/21.3 NS
- Fine Motor 5.2+/23.3 6.6+/23.0 4.5+/24.7 NS
- Gross Motor 8.4+/22.9 8.9+/22.6 7.8+/24.2 NS
- Respiratory 12.0+/20.0 11.6+/20.7 12.0+/20.0 NS
- Total 37.0+/25.7 37.5+/25.7 34.5+/29.0 NS
ACE-R
- Attention 8.8+/26.4 15.0+/24.7 14.5+/25.1 0.09a
- Memory 7.8+/27.9 18.9+/27.6 18.3+/26.8 0.06a,b
- Fluency 5.8+/25.2 6.4+/23.5 3.3+/25.3 NS
- Language 13.0+/29.4 19.3+/27.9 18.3+/23.0 NS
- Visuospatial 4.2+/23.8 12.0+/23.9 10.0+/24.4 ,0.05a,b
- Total 38.4+/231.7 71.5+/225.6 64.3+/219.2 NS
Although there were no differences in patient age, symptom duration, limb weakness, or limb functional capacity, patients with a an RMT,50% were significantly more
impaired on the visuospatial subtask of the ACE-R, with a trend for impaired performance on the attention and memory ACE-R sub-tasks. CBS = corticobasal syndrome,
RMT = resting motor threshold, MRCSS = medical research council sum score, ALSFRS-R = amyotrophic lateral sclerosis functional rating score – revised, ACE-R =
Addenbrooke’s cognitive examination – Revised, MMSE = mini-mental status examination. Note: P-Values quoted in the right hand column refer to inter-group
comparisons. Post-hoc pairwise comparisons are indicated by: aRMT ,50% versus RMT ,50%, P,0.05; bRMT ,50% versus Inexcitable, P = 0.063.
doi:10.1371/journal.pone.0092944.t004
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pencil or simply the interpretation of visual information. Similarly,
a correlation between impaired imitation of hand movements and
visuospatial dysfunction has been suggested in Parkinson’s
disease.[66] These results need to be interpreted with caution; it
is entirely possible that deficits in visual processing are responsible
for impaired imitation, rather than apraxia per se. On the other
hand, the correlation between limb apraxia and visuospatial
impairment does not confirm causality between the two deficits.
Although the precise relationship between limb apraxia and
visuospatial dysfunction remains to be elucidated, the results from
the present study suggest that limb apraxia could be partly due to
impaired visuospatial processing or visuomotor transcoding.[67]
Whether this relationship extends to aspects of apraxia not tested
through imitation remains unknown. Separately, difficulties in
imitation may need to be considered when designing and
administering physical therapies in patients with CBS.
The effect of asymmetric pathological involvement on apraxia
and visuospatial dysfunction in CBS is also unknown. In the
context of stroke, limb apraxia is much more likely after a left-
sided than a right-sided stroke.[68] In the present study, 7 patients
had symmetrical atrophy, whereas 10 had asymmetric atrophy (left
. right in all but one patient). No significant differences in the
visuospatial ACE-R or the apraxia subscore were detected
between the two groups. Unlike stroke patients, the locus of
pathology in CBS is virtually always bilateral, even when atrophy
is asymmetric. Nonetheless, in the presence of severe cortical
atrophy, both the right and left hemispheres may be affected,
making the distinction between left and right parietal contributions
to symptomatology very difficult to establish.
A clear consensus on the neuroanatomical basis of apraxia in
CBS has not yet emerged, perhaps reflective of the complex neural
networks involved in gesture production and tool usage. Through
lesional studies, several cerebral structures have been implicated in
Figure 3. Voxel-based morphometry analysis demonstrating
brain regions that positively correlate with neurophysiological
parameters in CBS patients. (A) Reduced RMT correlated with
atrophy of the primary motor cortex (red circles), thalamus (blue circle)
and the anterior temporal lobe (magenta circle). (B) Reduced SICI
correlated with atrophy of the primary motor cortex (red circle),
thalamus (blue circles), medial frontal cortex (yellow circles) and
precuneus (green circles). Clusters are overlaid on the Montreal
Neurological Institute standard brain (t.2.41). Colored voxels show
regions that were significant in the analyses for P,0.001 uncorrected
and a cluster threshold of 20 contiguous voxels. Circled areas indicate:
red = primary motor cortex; blue = thalamus; magenta = anterior
temporal lobe; yellow = medial frontal cortex; green = precuneus.
doi:10.1371/journal.pone.0092944.g003
Figure 4. Voxel-based morphometry analysis with the apraxia
score as a covariate in CBS patients. The degree of apraxia (as
reflected in an increased apraxia score) correlated with atrophy of the
medial frontal cortex (red circles) and the precuneus/posterior cingulate
(blue circles). Clusters are overlaid on the Montreal Neurological
Institute standard brain (t.2.41). Colored voxels show regions that
were significant in the analyses for P,0.001 uncorrected and a cluster
threshold of 20 contiguous voxels. Circled areas indicate: red = medial
frontal cortex; blue = precuneus/posterior cingulate.
doi:10.1371/journal.pone.0092944.g004
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the genesis of apraxia, including the left parietal lobe,[17,18,69,70]
frontoparietal circuits,[21] and the premotor cortex.[71–73]
Apraxia has also been described in the context of basal ganglia
pathology, particularly if surrounding white matter tracts are
involved.[74] In CBS, pathological studies have attributed apraxia
to involvement of the parietal, premotor, and primary motor
cortices.[23,71,75–77] Imaging studies in CBS have correlated
apraxia with inferior parietal,[21,22] left supplementary motor
area, premotor cortex, and caudate nucleus atrophy or dysfunc-
tional connectivity between these regions.[21,29] The parietal lobe
is important for integration of visual and sensory information,[78]
and involvement of this key integrative region in CBS is well
recognized, particularly in CBS associated with underlying
Alzheimer’s disease.[23,24] Our analyses suggest a strong
relationship between apraxia and atrophy of two regions; the
precuneus/posterior cingulate within the posteromedial parietal
lobe, and the premotor cortex. Interestingly, functional MRI
studies also support a key role for these two regions.[79] The
precuneus is known to be affected early in the course of
Alzheimer’s disease,[80] suggesting that the group of CBS patients
with underlying Alzheimer’s pathology may be driving the
association. Future studies should use amyloid imaging techniques
(such Pittsburgh compound type B positron emission tomography)
to explore this relationship. Furthermore, the precuneus/posterior
cingulate should be examined more closely in CBS patients with
underlying tau pathology.
In summary, cortical dysfunction in CBS is associated with
pathological involvement of the primary motor cortex and the
basal ganglia. Motor dysfunction, as assessed by transcranial
magnetic stimulation techniques, was associated with the degree of
apraxia. In addition, limb apraxia was correlated with atrophy of
the precuneus and the pre-motor cortex. Comparisons of cortical
excitability across different pathologies in CBS are required to
determine whether transcranial magnetic stimulation may be
useful in predicting pathology in life. Nonetheless, by combining
functional neurophysiological and neuropsychological methods, as
well as VBM, the present study provides further insight into the
pathogenesis of core clinical features of CBS.
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